REQUIRE POSTPARTUM IUD COVERAGE S.B. 987 & 988:
SUMMARY OF INTRODUCED BILL
IN COMMITTEE
Senate Bills 987 and 988 (as introduced 8-15-24)
Sponsor: Senator Mallory McMorrow
Committee: Health Policy
Date Completed: 9-24-24
CONTENT
Senate Bill 987 would amend Chapter 34 (Disability Insurance Policies) of the
Insurance Code to require insurers to provide coverage for immediate post-partum
intrauterine devices (IUDs) and contraceptive implants and associated anesthesia
services.
Senate Bill 988 would amend the Social Welfare Act to require Medicaid to provide
coverage for immediate post-partum IUDs and contraceptive implants and
associated anesthesia services.
Senate Bill 987
Under the bill, an insurer that delivered, issued for delivery, or renewed in Michigan a health
insurance policy would have to provide coverage for immediate post-partum IUDs and
contraceptive implants and associated anesthesia services. The coverage would be in addition
to a bundled reimbursement for labor and delivery, and an insurer could not consider the
devices, implants, services, or combination of devices, implants, or services to be part of a
payment for general obstetric procedures.
Senate Bill 988
The Social Welfare Act protects the welfare of Michigan residents. Generally, the Act provides
assistance, hospitalization, infirmary, and medical care to poor or unfortunate residents of
Michigan and provides for the welfare of the elderly, dependents, the blind, and permanently
and totally disabled individuals.
Beginning on the bill's effective date, the Department of Health and Human Services (DHHS)
would have to provide coverage under Medicaid for immediate postpartum IUDs and
contraceptive implants and associated anesthesia services. The coverage would be in addition
to a bundled reimbursement for labor and delivery, and the DHHS could not consider the
devices, implants, services, or combination of devices, implants, or services to be part of a
payment for general obstetric procedures.
Proposed MCL 500.3406kk (S.B. 987)
Proposed MCL 400.109p (S.B. 988)
BACKGROUND
According to the American College of Obstetricians and Gynecologists (ACOG), IUDs and
contraceptive implants are commonly referred to together as long-acting reversable
Page 1 of 2 sb987/988/2324
contraception (LARC).1 The advantage of LARC when compared to other reversable contraceptive
methods is that neither method requires ongoing effort on the part of the patient to be effective for
long periods of time. Intrauterine devices are small, T-shaped plastic devices that are inserted into
the uterus to prevent pregnancy. In the United States, IUDs are divided into two groups: those that
contain copper and those that release a type of synthetic compound meant to mimic a hormone
produced during pregnancy. Copper IUDs are 99.2% effective while hormonal IUDs are 99.8%
effective; however, copper IUDs maintain peak effectiveness longer.2 Contraceptive implants are
small, plastic rods inserted underneath the skin of the arm that release hormones to prevent
pregnancy. Contraceptive implants are 99.95% effective but require more frequent replacement
than IUDs to maintain peak effectiveness.3 The American College of Obstetricians and Gynecologists
suggests that benefits to getting LARC in the immediate postpartum period generally include: 1)
the patient is known not to be pregnant, constituting a potential opportunity to get LARC;4 2) the
patient may be motivated to avoid short-interval pregnancy (live births within 18 months of one
another);5 and 3) the patient and clinician are in the same place at the same time, eliminating
access barriers such as patients who do not show up for their follow-up visit.
Legislative Analyst: Alex Krabill
FISCAL IMPACT
Senate Bill 987
The bill would have no fiscal impact on State or local government.
Senate Bill 988
There could be a fiscal impact though likely minimal on the Medicaid program within the DHHS.
There would be no fiscal impact on local units of government.
According to the most recent version available of the Medicaid Provider Manual (July 1, 2024) the
Medicaid Hospital Reimbursement Appendix Special Circumstances Schedule covers: "LARC: An
additional payment for the LARC device will be made to a hospital when a LARC is provided
immediately postpartum. Practitioners will receive payment for their professional services related
to the immediate postpartum LARC insertion procedure when billed separately from the professional
global obstetric procedure codes and the hospital facility. Costs associated with a LARC device are
to be billed separately from the inpatient visit using the Medicaid fee schedule (insertion and
device)."
To the extent that the current Medicaid policy on LARCs is consistent with the specifications around
devices and implants as described in the bill, there would be no fiscal impact on the State.
Fiscal Analysts: Nathan Leaman
John P. Maxwell
1 ACOG, Long-Acting Reversible Contraception Implants and Intrauterine Devices, November 2017.
2 Id.
3 Id.
4
ACOG, Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversable Contraception,
August 2016.
5 Id.
SAS\S2324\s987sa
This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official
statement of legislative intent.
Page 2 of 2 Bill Analysis @ www.senate.michigan.gov/sfa sb987/988/2324


Statutes affected:
Senate Introduced Bill: 400.1, 400.119